Guadalupe Garcia-Tsao, MD; James L. Boyer, MD
Garcia-Tsao G., Boyer J.; Outpatient Liver Biopsy: How Safe Is It?. Ann Intern Med. 1993;118:150-153. doi: 10.7326/0003-4819-118-2-199301150-00013
Download citation file:
Published: Ann Intern Med. 1993;118(2):150-153.
Percutaneous liver biopsy is being done more frequently as a result of major changes in the therapy of liver diseases.The ease and safety of outpatient, “blind” liver biopsy has been well established. Complication rates have ranged from 0.9% to 3.7%; most complications have become manifest within the first 3 hours after biopsy, and none has resulted in death. Nevertheless, differing guidelines may affect relative degrees of safety in different Centers. A review of reported series suggests that the Menghini technique may be the preferred first choice, with the Tru-Cut technique reserved for patients in whom an adequate sample cannot be obtained. The requirement of a normal bleeding time appears to decrease the incidence of hemorrhagic complications. The decision to use outpatient biopsy must be based on a careful assessment of the risks and benefits for each individual patient.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only